Deal Library / Pharma BD Deal Intelligence

Vertex Pharmaceuticals Inc. — Pharma Deals

The Pharma Closeout tracks 5 deals, $9.8B in disclosed deal value, 5 with a post-close Outcome Score for Vertex Pharmaceuticals Inc..

Median Critic Score: 88 · Median Outcome Score: 78

All 5 deals

Vertex Pharmaceuticals Inc. / Semma Therapeutics Inc. — 2019 · $950M · Worked — the deal delivered on its rationale.
Vertex Pharmaceuticals Inc. / CRISPR Therapeutics AG — 2015 · $2.6B · Worked — the deal delivered on its rationale.
Vertex Pharmaceuticals Inc. / Alpine Immune Sciences — 2024 · $4.9B · Worked — the deal delivered on its rationale.
Vertex Pharmaceuticals Inc. / ViaCyte Inc. — 2022 · $320M · Largely worked — most objectives met.
Vertex Pharmaceuticals Inc. / Exonics Therapeutics — 2005 · $1.0B · Mixed — partial payoff, real shortfalls.